Obtenez les faits, trouvez le meilleur et évitez la fraude
Legal Name: DEERFIELD MANAGEMENT COMPANY, L.P. SERIES C
Période de rapport:
Jun 30, 2019
Date d\'entrée en vigueur:
Aug 14, 2019
| Sécurité |
Actions détenues / capital |
Valeur marchande |
Option |
|
HORIZON THERAPEUTICS PLC (G46188101)
|
6,462,634 |
$155,491k |
|
|
HORIZON PHARMA INVESTMENT LTD (44052TAB7)
|
136,032,000 |
$150,514k |
|
|
MYLAN N V (n59465109)
|
7,464,327 |
$142,121k |
|
|
ORCHARD THERAPEUTICS PLC (68570P101)
|
8,923,600 |
$124,841k |
|
|
NEVRO CORP (64157FAA1)
|
115,776,000 |
$120,607k |
|
|
Homology Medicines (438083107)
|
5,760,368 |
$112,730k |
|
|
AERIE PHARMACEUTICALS INC (00771V108)
|
3,032,987 |
$89,625k |
|
|
Intersect ENT Inc. (46071F103)
|
3,109,004 |
$70,761k |
|
|
IMMUNOMEDICS INC (452907108)
|
4,985,383 |
$69,147k |
|
|
Acceleron Pharma Inc (00434H108)
|
1,305,174 |
$53,617k |
|
|
INSULET CORP 1.375 11/15/24 (45784PAH4)
|
36,650,000 |
$52,097k |
|
|
BROOKDALE SENIOR LIVING INC (112463104)
|
7,207,239 |
$51,964k |
|
|
RA PHARMACEUTICALS (74933V108)
|
1,713,000 |
$51,510k |
|
|
ICPT 3 1/4 7/1/23 (45845PAA6)
|
57,791,000 |
$51,380k |
|
|
MYOKARDIA INC (62857M105)
|
997,000 |
$49,990k |
|
|
Sarepta Therapeutics Inc (803607100)
|
309,025 |
$46,956k |
|
|
DIPLOMAT PHARMACY INC (25456K101)
|
7,036,670 |
$42,853k |
|
|
Argenx SE Sponsored ADR (04016X101)
|
281,000 |
$39,784k |
|
|
VERICEL CORP (92346J108)
|
2,069,601 |
$39,095k |
|
|
MALLINCKRODT PLC (G5785G107)
|
4,178,219 |
$38,356k |
|
|
COHERUS BIOSCIENCES INC (19249H103)
|
1,678,022 |
$37,084k |
|
|
BLUEPRINT MEDICINES CORP (09627Y109)
|
391,254 |
$36,907k |
|
|
Fate Therapeutics Inc (31189P102)
|
1,702,897 |
$34,569k |
|
|
ALECTOR INC (014442107)
|
1,746,923 |
$33,192k |
|
|
SELECT MED HLDGS CORP (81619Q105)
|
2,043,527 |
$32,431k |
|
|
DEXCOM INC (252131AF4)
|
20,000,000 |
$31,926k |
|
|
KEMPHARM INC (488445AB3)
|
65,423,000 |
$31,632k |
|
|
Anaptysbio Inc (032724106)
|
540,529 |
$30,497k |
|
|
Editas Medicine Inc (28106W103)
|
1,158,841 |
$28,670k |
|
|
SIENTRA INC (82621J105)
|
4,652,306 |
$28,658k |
|
|
NATERA INC (632307104)
|
1,002,834 |
$27,658k |
|
|
PTC THERAPEUTICS INC (69366JAB7)
|
24,877,000 |
$27,557k |
|
|
MIRATI THERAPEUTICS INC (60468T105)
|
264,600 |
$27,254k |
|
|
XERIS PHARMACEUTICALS INC (98422L107)
|
2,379,901 |
$27,226k |
|
|
KALVISTA PHARMACEUTICALS (483497103)
|
1,217,668 |
$26,971k |
|
|
EHEALTH INC COM (28238P109)
|
310,900 |
$26,768k |
|
|
DBV TECHNOLOGIES SA-SPON ADR (23306J101)
|
3,201,222 |
$26,314k |
|
|
DFB HEALTHCARE ACQUISTION CORP UNIT EXP 013023 (23291E208)
|
2,500,000 |
$25,925k |
|
|
EXACT SCIENCES CORP (30063PAA3)
|
15,000,000 |
$25,846k |
|
|
STAAR SURGICAL CO COM NEW PAR $0.01 (852312305)
|
876,512 |
$25,752k |
|
|
NEVRO CORP COM (64157F103)
|
386,000 |
$25,024k |
|
|
SILK ROAD MEDICAL INC COM (82710M100)
|
499,030 |
$24,183k |
|
|
BIOCRYST PHARMACEUTICALS (09058v103)
|
6,292,980 |
$23,850k |
|
|
Invitae Corp (46185L103)
|
995,312 |
$23,390k |
|
|
MOLINA HEALTHCARE INC (60855R100)
|
150,000 |
$21,471k |
|
|
PTC THERAPEUTICS INC (69366J200)
|
471,000 |
$21,195k |
|
|
ARVINAS INC (04335A105)
|
921,234 |
$20,258k |
|
|
WRIGHT MED GROUP N V (98236JAB4)
|
13,625,000 |
$20,185k |
|
|
ADDUS HOMECARE CORP (006739106)
|
252,915 |
$18,956k |
|
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
493,901 |
$18,699k |
|
|
Reata Pharmaceuticals Inc. (75615P103)
|
197,000 |
$18,587k |
|
|
SHOCKWAVE MED INC COM (82489T104)
|
312,146 |
$17,820k |
|
|
HUMANA INC (444859102)
|
67,000 |
$17,775k |
|
|
KINISKA PHARMACEUTIC (G5269C101)
|
1,310,259 |
$17,741k |
|
|
AXOGEN INC COM (05463X106)
|
891,306 |
$17,648k |
|
|
WAVE LIFE SCIENCES LTD (Y95308105)
|
669,260 |
$17,461k |
|
|
ROCKET PHARMACEUTICALS INC (77313F106)
|
1,137,142 |
$17,057k |
|
|
CLOVIS ONCOLOGY INC (189464AB6)
|
18,000,000 |
$15,902k |
|
|
CENTENE CORP DEL (15135B101)
|
303,000 |
$15,889k |
|
|
ANTHEM INC (036752103)
|
53,000 |
$14,957k |
|
|
MorphoSys AG (617760202)
|
600,000 |
$14,484k |
|
|
Rhythm Pharmaceuticals, Inc. (76243J105)
|
623,933 |
$13,727k |
|
|
DECIPHERA PHARMACEUTICALS IN (24344T101)
|
607,633 |
$13,702k |
|
|
GALAPAGOS NV (36315X101)
|
101,010 |
$13,023k |
|
|
GLOBAL BLOOD THERAPEUTICS IN (37890U108)
|
235,000 |
$12,361k |
|
|
ATHENEX INC (04685N103)
|
621,859 |
$12,313k |
|
|
Syros Pharmaceuticals Inc (87184Q107)
|
1,268,946 |
$11,750k |
|
|
TURNING POINT THERAPEUTICS I (90041T108)
|
287,545 |
$11,703k |
|
|
PHASEBIO PHARMACEUTICALS INC (717224109)
|
851,005 |
$11,165k |
|
|
SYNLOGIC INC (87166L100)
|
1,107,643 |
$10,080k |
|
|
TANDEM DIABETES CARE (875372203)
|
152,500 |
$9,839k |
|
|
ARDELYX INC (039697107)
|
3,461,298 |
$9,311k |
|
|
INSPIRE MED SYS INC COM (457730109)
|
151,106 |
$9,165k |
|
|
CHEWY INC CL A (16679L109)
|
261,337 |
$9,147k |
|
|
ACLARIS THERAPEUTICS INC (00461U105)
|
3,983,025 |
$8,723k |
|
|
X4 PHARMACEUTICALS INC (98420X103)
|
565,000 |
$8,475k |
|
|
AVADEL PHARMACEUTICALS PLC (05337M104)
|
2,722,241 |
$7,867k |
|
|
BRIDGEBIO PHARMA INC (10806X102)
|
290,000 |
$7,821k |
|
|
SORRENTO THERAPEUTICS INC (83587F202)
|
2,091,461 |
$5,584k |
|
|
B. Riley Wealth Management, Inc. (016259103)
|
6,052,935 |
$5,387k |
|
|
TELIGENT INC/NJ (87960WAA2)
|
9,567,000 |
$5,063k |
|
|
IDEAYA BIOSCIENCES INC (45166A102)
|
425,000 |
$4,233k |
|
|
BIODELIVERY SCI INTL (09060J106)
|
816,096 |
$3,795k |
|
|
HARPOON THERAPEUTICS INC (41358P106)
|
285,000 |
$3,705k |
|
|
MEDICINES CO (584688105)
|
100,000 |
$3,647k |
Put |
|
ITAMAR MED LTD (465437101)
|
314,136 |
$3,455k |
|
|
AEGLEA BIOTHERAPEUTICS INC (00773J103)
|
500,046 |
$3,425k |
|
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
70,000 |
$3,381k |
|
|
PFENEX INC (717071104)
|
394,255 |
$2,657k |
|
|
CONSTELLATION PHARMCETICLS I (210373106)
|
183,600 |
$2,255k |
|
|
NEURONETICS (64131A105)
|
159,000 |
$1,989k |
|
|
Alpine Immune Sciences Inc (02083G100)
|
415,908 |
$1,751k |
|
|
EYENOVIA INC (30234E104)
|
300,000 |
$1,290k |
|
|
ORTHOPEDIATRICS CORP (68752L100)
|
32,000 |
$1,248k |
|
|
MENLO THERAPEUTICS (586858102)
|
198,451 |
$1,189k |
|
|
PROTEON THERAPEUTICS INC (74371L109)
|
1,224,899 |
$510k |
|
|
NEOS THERAPEUTICS INC (64052L106)
|
320,993 |
$414k |
|
De nombreuses personnes ont été brûlées par des fraudes et des stratagèmes de Ponzi. Nous avons donc créé ce site Web pour vous aider, en tant qu’investisseur potentiel, à obtenir les faits, à trouver le meilleur des moyens, et à éviter la fraude et les stratagèmes de Ponzi.
Toutes les informations fournies sur ce site sont fournies sans garantie et à des fins d'information uniquement.
InvestingReview.org ne fournit pas de conseils en investissement. InvestingReview.org n'est pas un conseiller en investissement et n'est ni endossé ni affilié à un organisme de réglementation américain ou non américain.
Entreprises récemment recherchées
Remarque: les données de recherche sont accumulées par des tiers et actualisées une fois par jour.